{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T13:55:34Z","timestamp":1740146134007,"version":"3.37.3"},"reference-count":50,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2016,10,13]],"date-time":"2016-10-13T00:00:00Z","timestamp":1476316800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Ministry of Science of Technology, Taiwan, ROC","award":["MOST103-2221-E-194-045-MY3, MOST104-2627-B-194-001, and MOST105-2627-M-194-001"],"award-info":[{"award-number":["MOST103-2221-E-194-045-MY3, MOST104-2627-B-194-001, and MOST105-2627-M-194-001"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0164589","type":"journal-article","created":{"date-parts":[[2016,10,13]],"date-time":"2016-10-13T18:00:58Z","timestamp":1476381658000},"page":"e0164589","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":1,"title":["Fuzzy Decision Making Approach to Identify Optimum Enzyme Targets and Drug Dosage for Remedying Presynaptic Dopamine Deficiency"],"prefix":"10.1371","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3640-1634","authenticated-orcid":true,"given":"Kai-Cheng","family":"Hsu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng-Sheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2016,10,13]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1146\/annurev.neuro.22.1.123","article-title":"Etiology and pathogenesis of Parkinson&apos;s disease","volume":"22","author":"CW Olanow","year":"1999","journal-title":"Annu Rev Neurosci"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.euroneuro.2005.04.007","article-title":"Prevalence and incidence of Parkinson&apos;s disease in Europe","volume":"15","author":"S von Campenhausen","year":"2005","journal-title":"Eur Neuropsychopharmacol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"e1004609","DOI":"10.1371\/journal.pcbi.1004609","article-title":"Computational models describing possible mechanisms for generation of excessive beta oscillations in Parkinson\u2019s disease","volume":"11","author":"A Pavlides","year":"2015","journal-title":"PLOS Computational Biology"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"e1000670","DOI":"10.1371\/journal.pcbi.1000670","article-title":"A kinetic model of dopamine- and calcium-dependent striatal synaptic plasticity","volume":"6","author":"T Nakano","year":"2010","journal-title":"PLoS Computational Biology"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"e37564","DOI":"10.1371\/journal.pone.0037564","article-title":"Dopamine induced neurodegeneration in a PINK1 model of Parkinson&apos;s disease","volume":"7","author":"S Gandhi","year":"2012","journal-title":"PLoS One"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1056\/NEJM198911163212004","article-title":"Effect of deprenyl on the progression of disability in early Parkinson&apos;s disease","volume":"321","year":"1989","journal-title":"N Engl J Med"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1056\/NEJM199301213280305","article-title":"Effects of tocopherol and deprenyl on the progression of disability in early Parkinson&apos;s disease","volume":"328","year":"1993","journal-title":"N Engl J Med"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/ana.410390107","article-title":"Impact of deprenyl and tocopherol treatment on Parkinson&apos;s disease in DATATOP patients requiring levodopa","volume":"39","year":"1996","journal-title":"Ann Neurol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/ana.410390106","article-title":"Impact of deprenyl and tocopherol treatment on Parkinson&apos;s disease in DATATOP subjects not requiring levodopa","volume":"39","year":"1996","journal-title":"Ann Neurol"},{"key":"ref10","first-page":"CD006661","article-title":"Monoamine oxidase B inhibitors versus other dopaminergic agents in early Parkinson&apos;s disease","volume":"4","author":"R Caslake","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"ref11","unstructured":"Pharmaceutical research and manufactures of America. Biopharmaceutical research &amp; development: The process behind new medicines. 2015. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.phrma.org\/sites\/default\/files\/pdf\/rd_brochure_022307.pdf\" xlink:type=\"simple\">http:\/\/www.phrma.org\/sites\/default\/files\/pdf\/rd_brochure_022307.pdf<\/ext-link>"},{"key":"ref12","unstructured":"Strovel J, Sittampalam S, Coussens NP, Hughes M, Inglese J, Kurtz A, et al. Early drug discovery and development guidelines: for academic researchers, collaborators, and start-up companies. 2012 May 1. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK92015\/\" xlink:type=\"simple\">http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK92015\/<\/ext-link>"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1111\/j.1476-5381.2010.01127.x","article-title":"Principles of early drug discovery","volume":"162","author":"JP Hughes","year":"2011","journal-title":"Br J Pharmacol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/j.drudis.2006.10.004","article-title":"Systems biology, metabolic modelling and metabolomics in drug discovery and development","volume":"11","author":"DB Kell","year":"2006","journal-title":"Drug Discov Today"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/S1359-6446(02)02280-8","article-title":"Metabolic modeling: a tool of drug discovery in the post-genomic era","volume":"7","author":"EO Voit","year":"2002","journal-title":"Drug Discov Today"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"e427","DOI":"10.1016\/j.ddtec.2013.02.001","article-title":"Multi-objective optimization methods in drug design","volume":"10","author":"CA Nicolaou","year":"2013","journal-title":"Drug Discov Today Technol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"e43487","DOI":"10.1371\/journal.pone.0043487","article-title":"Identifying the preferred subset of enzymatic profiles in nonlinear kinetic metabolic models via multiobjective global optimization and pareto filters","volume":"7","author":"C Pozo","year":"2012","journal-title":"PLoS ONE"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1186\/1471-2105-10-386","article-title":"Identifying quantitative operation principles in metabolic pathways: a systematic method for searching feasible enzyme activity patterns leading to cellular adaptive responses","volume":"10","author":"G Guillen-Gosalbez","year":"2009","journal-title":"BMC Bioinformatics"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.drudis.2007.02.013","article-title":"Computational systems biology in drug discovery and development: methods and applications","volume":"12","author":"W Materi","year":"2007","journal-title":"Drug Discov Today"},{"issue":"Suppl 9","key":"ref20","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1177\/0091270010377628","article-title":"Model-based drug development survey finds pharmacometrics impacting decision making in the pharmaceutical industry","volume":"50","author":"JA Stone","year":"2010","journal-title":"J Clin Pharmacol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1093\/bioinformatics\/btm326","article-title":"Detection of potential enzyme targets by metabolic modelling and optimization: application to a simple enzymopathy","volume":"23","author":"J Vera","year":"2007","journal-title":"Bioinformatics"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/j.cor.2009.02.021","article-title":"Optimization of biochemical systems through mathematical programming: Methods and applications","volume":"37","author":"J Vera","year":"2010","journal-title":"Computers & Operations Research"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1002\/sim.4780140911","article-title":"Estimating the minimum therapeutically effective dose of a compound via regression modelling and percentile estimation","volume":"14","author":"TG Filloon","year":"1995","journal-title":"Stat Med"},{"first-page":"12","year":"2013","author":"GP Rangaiah","key":"ref24"},{"first-page":"296","year":"1985","author":"Y Sawaragi","key":"ref25"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"3191","DOI":"10.1093\/bioinformatics\/btt564","article-title":"Fuzzy optimization for detecting enzyme targets of human uric acid metabolism","volume":"29","author":"KC Hsu","year":"2013","journal-title":"Bioinformatics"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"e1004012","DOI":"10.1371\/journal.pcbi.1004012","article-title":"150 years of the mass action law","volume":"11","author":"EO Voit","year":"2015","journal-title":"PLoS Computational Biology"},{"key":"ref28","doi-asserted-by":"crossref","unstructured":"Voit EO. Biochemical systems theory (BST): A review. International Scholarly Research Network (ISRN)\u2014Biomathematics; 2013. pp. 1\u201353.","DOI":"10.1007\/978-1-4419-9863-7_1240"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1002\/bit.1135","article-title":"Assessment of effects of experimental imprecision on optimized biochemical systems","volume":"74","author":"EO Voit","year":"2001","journal-title":"Biotechnology and Bioengineering"},{"first-page":"308","year":"1993","author":"M Sakawa","key":"ref30"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/1752-0509-5-145","article-title":"Multi-objective optimization of enzyme manipulations in metabolic networks considering resilience effects","volume":"5","author":"WH Wu","year":"2011","journal-title":"BMC Syst Biol"},{"first-page":"95","year":"2011","author":"MR Bussieck","key":"ref32"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1002\/bit.21679","article-title":"Yield optimization of regulated metabolic systems using deterministic branch-and-reduce methods","volume":"99","author":"PK Polisetty","year":"2008","journal-title":"Biotechnology and Bioengineering"},{"key":"ref34","first-page":"38","article-title":"Optimization of biotechnological systems through geometric programming","volume":"74","author":"A Marin-Sanguino","journal-title":"Theoretical Biology and Medical Modelling"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jtice.2015.03.015","article-title":"Optimal design of growth-coupled production strains using nested hybrid differential evolution","volume":"54","author":"FS Wang","year":"2015","journal-title":"Journal of the Taiwan Institute of Chemical Engineers"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"e2444","DOI":"10.1371\/journal.pone.0002444","article-title":"Computational systems analysis of dopamine metabolism","volume":"3","author":"Z Qi","year":"2008","journal-title":"PLoS One"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"2622","DOI":"10.1111\/j.1460-9568.2006.05143.x","article-title":"Age-related decline in striatal dopamine content and motor performance occurs in the absence of nigral cell loss in a genetic mouse model of Parkinson&apos;s disease","volume":"24","author":"RE Colebrooke","year":"2006","journal-title":"Eur J Neurosci"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"5321","DOI":"10.1128\/MCB.21.16.5321-5331.2001","article-title":"Mice with very low expression of the vesicular monoamine transporter 2 gene survive into adulthood: potential mouse model for parkinsonism","volume":"21","author":"KA Mooslehner","year":"2001","journal-title":"Mol Cell Biol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"9938","DOI":"10.1073\/pnas.94.18.9938","article-title":"VMAT2 knockout mice: heterozygotes display reduced amphetamine-conditioned reward, enhanced amphetamine locomotion, and enhanced MPTP toxicity","volume":"94","author":"N Takahashi","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"e00149","DOI":"10.1002\/prp2.149","article-title":"Analysis of drug combinations: current methodological landscape","volume":"3","author":"J Foucquier","year":"2015","journal-title":"Pharmacol Res Perspect"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.tins.2009.01.006","article-title":"Calcium homeostasis, selective vulnerability and Parkinson&apos;s disease","volume":"32","author":"CS Chan","year":"2009","journal-title":"Trends Neurosci"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1111\/j.1471-4159.2006.03941.x","article-title":"Evidence for L-dopa incorporation into cell proteins in patients treated with levodopa","volume":"98","author":"KJ Rodgers","year":"2006","journal-title":"J Neurochem"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1002\/mds.20243","article-title":"Levodopa in the treatment of Parkinson&apos;s disease: current controversies","volume":"19","author":"CW Olanow","year":"2004","journal-title":"Mov Disord"},{"issue":"Suppl 3","key":"ref44","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1002\/ana.10513","article-title":"Limitations of current Parkinson&apos;s disease therapy","volume":"53","author":"O Rascol","year":"2003","journal-title":"Ann Neurol"},{"issue":"Suppl 2","key":"ref45","article-title":"Levodopa\u2014an exotoxin or a therapeutic drug?","volume":"247","author":"E Melamed","year":"2000","journal-title":"J Neurol"},{"issue":"Suppl 6","key":"ref46","article-title":"Is levodopa toxic?","volume":"251","author":"T Muller","year":"2004","journal-title":"J Neurol"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/0006-8993(95)00341-M","article-title":"Toxic effects of L-DOPA on mesencephalic cell cultures: protection with antioxidants","volume":"682","author":"B Pardo","year":"1995","journal-title":"Brain Res"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.1172\/JCI117946","article-title":"Induction of apoptosis in catecholaminergic PC12 cells by L-DOPA. Implications for the treatment of Parkinson&apos;s disease","volume":"95","author":"G Walkinshaw","year":"1995","journal-title":"J Clin Invest"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1166\/jctn.2013.2804","article-title":"Identifying multi-functional enzyme by hierarchical multi-label classifier","volume":"10","author":"Q Zou","year":"2013","journal-title":"J Comput Theor Nanosci"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"e0153503","DOI":"10.1371\/journal.pone.0153503","article-title":"Identification of multi-functional enzyme with multi-label classifier","volume":"11","author":"Y Che","year":"2016","journal-title":"PLoS ONE"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0164589","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T10:14:52Z","timestamp":1589019292000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0164589"}},"subtitle":[],"editor":[{"given":"Quan","family":"Zou","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2016,10,13]]},"references-count":50,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2016,10,13]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0164589","relation":{},"ISSN":["1932-6203"],"issn-type":[{"type":"electronic","value":"1932-6203"}],"subject":[],"published":{"date-parts":[[2016,10,13]]}}}